Emrock Corporation Forms Pharma LLP with 50.5% Stake

Emrock Corporation Board approved incorporation of an LLP for strategic expansion into the pharmaceutical and healthcare sector.
The proposed LLP will engage in pharma product manufacturing, trading, distribution, and import/export activities.
The company will hold a 50.50% stake and profit-sharing ratio in the new pharmaceutical venture.